Physician profile

Alexa M Paley

Physician Assistant · Omaha, NE

NPI 1942852199

$7,997.18

in general payments reported to CMS, 2019-2025

37 companies · $2,044 in 2025

The $2,044 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).

See the full distribution for Physician Assistant

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,015.84
Travel and Lodging$1,554.89
Education$159.94

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Penumbra, INC. $2,864.55 2021-2025 Indigo System, Penumbra System, Smart Coil
W. L. Gore & Associates, INC. $939.77 2021-2025 Gore Tag Thoracic Branch Endoprosthesis, Gore Acuseal Vascular Graft, Gore Tag Conformable Thoracic Endoprosthesis
Silk Road Medical, INC. $801.96 2021-2024 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter
Bard Peripheral Vascular, INC. $438.50 2021-2024 Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon
Abbvie INC. $347.17 2025
Angiodynamics, INC. $276.26 2022-2023 Auryon Laser System 100-120 Vac
Janssen Biotech, INC. $263.97 2025 Tremfya
Novartis Pharmaceuticals Corporation $226.66 2025
Shockwave Medical, INC $175.95 2022
Genzyme Corporation $172.11 2025
Sun Pharmaceutical Industries INC. $159.26 2025
Lilly USA, LLC $149.71 2025 Taltz, Ebglyss
Endologix LLC $134.23 2024
Ucb, INC. $103.49 2025 Bimzelx
Incyte Corporation $87.12 2025 Opzelura
Show all 37 companies
CompanyGeneral paymentsYearsTop products
Amgen INC. $86.54 2025 Otezla
Integra Lifesciences Corporation $65.61 2023-2024 Integra, Primatrix, Integra Dermal Regeneration Template
Lemaitre Vascular, INC. $63.36 2021
Pfizer INC. $60.97 2025
Galderma Laboratories, L.P. $58.62 2025 Nemluvio
Abbott Laboratories $57.81 2025 Esprit, Femostop
Regeneron Healthcare Solutions, INC. $52.47 2025 Dupixent
Bolton Medical INC $50.89 2024 Treo Abdominal Stent-Graft System
Edwards Lifesciences Corporation $49.53 2024 Sapien 3 Ultra Resilia
E.R. Squibb & Sons, L.L.C. $36.79 2022-2025 Sotyktu
Smith+Nephew, INC. $35.65 2023 Renasys Go V2 Home, Pico
Tactile Systems Technology INC $34.03 2025 Nimbl, Flexitouch Plus
Botanix Sb INC $31.82 2025 Sofdra
Kci USA, INC. $27.54 2023 Activ.A.C.
Medtronic, INC. $23.98 2021
Convatec INC. $22.18 2024
Boston Scientific Corporation $22.05 2024 Ekosonic
Leo Pharma INC. $21.93 2025 Anzupgo
Solventum Corporation $16.25 2025 Activ.A.C.
Boehringer Ingelheim Pharmaceuticals, INC. $14.54 2025 Spevigo
Cardiva Medical, INC. $12.86 2022
Janssen Pharmaceuticals, INC $11.05 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Alexa M Paley

$7,997.18

in general payments reported 2019-2025

Years
2021-2025
Top company
Penumbra, INC.
Context
The $2,044 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).

https://glasscript.com/doctor/10938211/alexa-m-paley

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.